SymbolBLCO
NameBAUSCH + LOMB CORPORATION COMMON SHARES
SectorUNDEFINED
RegionUNDEFINED
IndustryOphthalmic Goods
Address520 APPLEWOOD CRESCENT, VAUGHAN, Ontario, L4K 4B4, Canada
Telephone+1 905 695-7700
Fax
Email
Website
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001860742
Description

Bausch & Lomb, headquartered in Laval, Quebec, Canada, is the fourth-largest vision care company by sales in the United States and the market leader in consumer vision care in India and China. The firm, which was previously a subsidiary under parent company Bausch Health, was spun off to become a public company once again in May 2022. The firm reports in three segments-vision care and consumer (60% of revenue), surgical (20%), and ophthalmic pharmaceuticals (20%). The company is geographically diversified, with 48% of revenue in the Americas, 30% from EMEA, and 22% from Asia-Pacific countries.

Additional info from NASDAQ:
Bausch & Lomb, headquartered in Laval, Quebec, Canada, is the fourth-largest vision care company by sales in the United States and the market leader in consumer vision care in India and China. The firm, which was previously a subsidiary under parent company Bausch Health, was spun off to become a public company once again in May 2022. The firm reports in three segments-vision care and consumer (60% of revenue), surgical (20%), and ophthalmic pharmaceuticals (20%). The company is geographically diversified, with 48% of revenue in the Americas, 30% from EMEA, and 22% from Asia-Pacific countries.

2026-07-06 11:15

Bausch + Lomb Will Release Second-Quarter 2026 Financial Results on July 29

Read more
2026-07-01 11:00

New Bausch + Lomb Data Show that Addressing Dry Eye Symptoms is Associated with Improved Quality of Life, Including Lower Anxiety and Increased Self-Confidence

Read more
2026-06-16 20:16

Bonnefoy Luc 🔴 sold 1.0K shares of Bausch & Lomb Corp (BLCO) at $15.08 Transaction Date: Jun 12, 2026 | Filing ID: 000084

Read more
2026-06-01 17:11

New Form SD - Bausch & Lomb Corp <b>Filed:</b> 2026-06-01 <b>AccNo:</b> 0001860742-26-000083 <b>Size:</b> 52 KB

Read more
2026-06-01 10:59

Bausch + Lomb Launches Blink® Triple Care Preservative Free Lubricant Eye Drops in the United States

Read more
2026-05-28 21:10

Director VON ESCHENBACH ANDREW C. 🟢 acquired 15.8K shares of Bausch & Lomb Corp (BLCO) at $15.78 Transaction Date: May 26, 2026 | Filing ID: 000082

Read more
2026-05-28 21:09

Director Ross Thomas W. Sr. 🟢 acquired 15.8K shares of Bausch & Lomb Corp (BLCO) at $15.78 Transaction Date: May 26, 2026 | Filing ID: 000081

Read more
2026-05-28 21:07

Director ROBERTSON RUSSEL C 🟢 acquired 15.8K shares of Bausch & Lomb Corp (BLCO) at $15.78 Transaction Date: May 26, 2026 | Filing ID: 000080

Read more
2026-05-28 21:07

Director Paulson John 🟢 acquired 15.8K shares of Bausch & Lomb Corp (BLCO) at $15.78 Transaction Date: May 26, 2026 | Filing ID: 000079

Read more
2026-05-28 21:05

Director Ling Karen 🟢 acquired 15.8K shares of Bausch & Lomb Corp (BLCO) at $15.78 Transaction Date: May 26, 2026 | Filing ID: 000078

Read more